VanEck Pharmaceutical ETF (NASDAQ:PPH) Short Interest Up 26.9% in November

VanEck Pharmaceutical ETF (NASDAQ:PPH) saw a significant increase in short interest during the month of November. As of November 15th, there was short interest totalling 2,360,000 shares, an increase of 26.9% from the October 31st total of 1,860,000 shares. Based on an average daily trading volume, of 194,300 shares, the short-interest ratio is presently 12.1 days.

Hedge Funds Weigh In On VanEck Pharmaceutical ETF

Institutional investors and hedge funds have recently bought and sold shares of the business. Private Advisory Group LLC lifted its stake in VanEck Pharmaceutical ETF by 0.3% in the second quarter. Private Advisory Group LLC now owns 37,994 shares of the company’s stock valued at $3,476,000 after acquiring an additional 128 shares during the last quarter. Townsquare Capital LLC boosted its holdings in VanEck Pharmaceutical ETF by 3.8% in the third quarter. Townsquare Capital LLC now owns 3,519 shares of the company’s stock worth $334,000 after purchasing an additional 130 shares in the last quarter. FMR LLC increased its position in VanEck Pharmaceutical ETF by 12.5% during the third quarter. FMR LLC now owns 1,905 shares of the company’s stock worth $181,000 after buying an additional 212 shares during the last quarter. Optimum Investment Advisors bought a new position in VanEck Pharmaceutical ETF during the second quarter valued at about $27,000. Finally, Beck Capital Management LLC lifted its position in shares of VanEck Pharmaceutical ETF by 1.5% in the second quarter. Beck Capital Management LLC now owns 21,274 shares of the company’s stock worth $1,946,000 after buying an additional 317 shares during the last quarter.

VanEck Pharmaceutical ETF Price Performance

Shares of VanEck Pharmaceutical ETF stock opened at $90.14 on Monday. VanEck Pharmaceutical ETF has a 1-year low of $77.61 and a 1-year high of $99.51. The company has a market capitalization of $666.13 million, a P/E ratio of 21.04 and a beta of 0.72. The business’s fifty day moving average price is $91.95 and its two-hundred day moving average price is $93.03.

VanEck Pharmaceutical ETF Company Profile

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.